These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2564808

  • 21. Mechanism of dexamethasone 21-mesylate antiglucocorticoid action: I. Receptor-antiglucocorticoid complexes do not competitively inhibit receptor-glucocorticoid complex activation of gene transcription in vivo.
    Sistare FD, Hager GL, Simons SS.
    Mol Endocrinol; 1987 Sep; 1(9):648-58. PubMed ID: 3153481
    [Abstract] [Full Text] [Related]

  • 22. The acute effect of lead acetate on glucocorticoid regulation of tyrosine aminotransferase in hepatoma cells.
    Heiman AS, Tonner LE.
    Toxicology; 1995 Jun 26; 100(1-3):57-68. PubMed ID: 7624883
    [Abstract] [Full Text] [Related]

  • 23. Description and analysis of differential sensitivity to glucocorticoids in Fao cells.
    Gagne D, Labhilili M, Pons M.
    J Steroid Biochem; 1988 Dec 26; 31(6):917-25. PubMed ID: 2904511
    [Abstract] [Full Text] [Related]

  • 24. Cross-talk modulation of signal transduction pathways: two mechanisms are involved in the control of tyrosine aminotransferase gene expression by phorbol esters.
    Reik A, Stewart AF, Schütz G.
    Mol Endocrinol; 1994 Apr 26; 8(4):490-7. PubMed ID: 7914348
    [Abstract] [Full Text] [Related]

  • 25. Transcriptional and posttranscriptional regulation of tyrosine aminotransferase by insulin in rat hepatoma cells.
    Crettaz M, Muller-Wieland D, Kahn CR.
    Biochemistry; 1988 Jan 12; 27(1):495-500. PubMed ID: 2894848
    [Abstract] [Full Text] [Related]

  • 26. Modulation of the agonist activity of antisteroids by a novel cis-acting element.
    Simons SS, Oshima H, Szapary D.
    J Steroid Biochem Mol Biol; 1992 Sep 12; 43(1-3):43-55. PubMed ID: 1356017
    [Abstract] [Full Text] [Related]

  • 27. Synergistic induction of tissue-type plasminogen activator gene expression by glucocorticoids and cyclic nucleotides in rat HTC hepatoma cells.
    Kathju S, Heaton JH, Bruzdzinski CJ, Gelehrter TD.
    Endocrinology; 1994 Sep 12; 135(3):1195-204. PubMed ID: 8070363
    [Abstract] [Full Text] [Related]

  • 28. Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids.
    Schuetz JD, Silverman JA, Thottassery JV, Furuya KN, Schuetz EG.
    Cell Growth Differ; 1995 Oct 12; 6(10):1321-32. PubMed ID: 8845310
    [Abstract] [Full Text] [Related]

  • 29. [Use of the tyrosine aminotransferase induction system for the demonstration of the signal effect of glucocorticoid hormones].
    Giesen EM, Beck G.
    C R Seances Soc Biol Fil; 1981 Oct 12; 175(1):104-8. PubMed ID: 6112052
    [Abstract] [Full Text] [Related]

  • 30. Effect of potent antiglucocorticoids on dexamethasone induced enzymes in cultured hepatoma and rat liver cells.
    Santana MA, Chasserot-Bolaz S, Beck B, Pogson CI.
    Cancer Lett; 1985 Jul 12; 27(3):329-37. PubMed ID: 2861890
    [Abstract] [Full Text] [Related]

  • 31. Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
    Vannice JL, Grove JR, Ringold GM.
    Mol Pharmacol; 1983 May 12; 23(3):779-85. PubMed ID: 6135149
    [Abstract] [Full Text] [Related]

  • 32. Inhibition by sodium butyrate of enzyme induction by glucocorticoids and dibutyryl cyclic AMP. A role for the rapid form of histone acetylation.
    Plesko MM, Hargrove JL, Granner DK, Chalkley R.
    J Biol Chem; 1983 Nov 25; 258(22):13738-44. PubMed ID: 6196355
    [Abstract] [Full Text] [Related]

  • 33. Differences in rates of tyrosine aminotransferase deinduction with cyclic AMP and glucocorticoids.
    Lewis EJ, Calie P, Wicks WD.
    Proc Natl Acad Sci U S A; 1982 Oct 25; 79(19):5778-82. PubMed ID: 6136964
    [Abstract] [Full Text] [Related]

  • 34. Unique long-acting antiglucocorticoid in whole and broken cell systems.
    Simons SS, Thompson EB, Johnson DF.
    Proc Natl Acad Sci U S A; 1980 Sep 25; 77(9):5167-71. PubMed ID: 6107912
    [Abstract] [Full Text] [Related]

  • 35. Paradoxical effects of glucocorticoids on regulation of plasminogen activator activity. Mediation by glucocorticoid receptors.
    Barouski-Miller PA, Gelehrter TD.
    J Steroid Biochem; 1984 Feb 25; 20(2):533-7. PubMed ID: 6142981
    [Abstract] [Full Text] [Related]

  • 36. [Differences in expression and functional organization of the rat tyrosine aminotransferase gene in two lines of Morris hepatoma, 8994 and 7777].
    Adler VV, Kiseleva NP, Kistanova EN, Klenova EM, Lobanenkov VV, Polotskaia AV, Tevosian SG.
    Mol Biol (Mosk); 1991 Feb 25; 25(2):431-41. PubMed ID: 1679193
    [Abstract] [Full Text] [Related]

  • 37. RU 38486: a potent antiglucocorticoid in vitro and in vivo.
    Gagne D, Pons M, Philibert D.
    J Steroid Biochem; 1985 Sep 25; 23(3):247-51. PubMed ID: 2864478
    [Abstract] [Full Text] [Related]

  • 38. Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.
    Heaton JH, Gelehrter TD.
    Mol Endocrinol; 1989 Feb 25; 3(2):349-55. PubMed ID: 2469009
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of steroid-inducible tyrosine aminotransferase gene expression by N-methyl-N'-nitro-N-nitrosoguanidine in a rat hepatoma cell line.
    Miller MS, Wogan GN.
    Carcinogenesis; 1986 Aug 25; 7(8):1273-8. PubMed ID: 2873903
    [Abstract] [Full Text] [Related]

  • 40. Calreticulin inhibits glucocorticoid- but not cAMP-sensitive expression of tyrosine aminotransferase gene in cultured McA-RH7777 hepatocytes.
    Burns K, Opas M, Michalak M.
    Mol Cell Biochem; 1997 Jun 25; 171(1-2):37-43. PubMed ID: 9201693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.